Are smoking cessation treatments associated with suicidality risk? An overview

Simple item page
dc.contributor.authorPenberthy, J. Kim
dc.contributor.authorPenberthy, J. Morgan
dc.contributor.authorHarris, Marcus R.
dc.contributor.authorNanda, Sonali
dc.contributor.authorAhn, Jennifer
dc.contributor.authorMartinez, Caridad Ponce
dc.contributor.authorOsika, Apule O.
dc.contributor.authorSlepian, Zoe A.
dc.contributor.authorForsyth, Justin C.
dc.contributor.authorStarr, J. Andrew
dc.contributor.authorFarrell, Jennifer E.
dc.contributor.authorHook, Joshua N.
dc.date.accessioned2019-11-27T10:38:07Z
dc.date.available2019-11-27T10:38:07Z
dc.date.issued2016-01-27
dc.description.abstractRisk of suicidality during smoking cessation treatment is an important, but often overlooked, aspect of nicotine addiction research and treatment. We explore the relationship between smoking cessation interventions and suicidality and explore common treatments, their associated risks, and effectiveness in promoting smoking reduction and abstinence. Although active smokers have been reported to have twofold to threefold increased risk of suicidality when compared to nonsmokers,14 research regarding the safest way to stop smoking does not always provide clear guidelines for practitioners wishing to advise their patients regarding smoking cessation strategies. In this article, we review pharmacological and cognitive behavioral therapy (CBT) options that are available for people seeking to quit smoking, focusing on the relationship between the ability of these therapies to reduce smoking behavior and promote abstinence and suicidality risks as assessed by reported suicidality on validated measures, reports of suicidal ideation, behaviors, actual attempts, or completed suicides. Pharmacotherapies such as varenicline, bupropion, and nicotine replacement, and CBTs, including contextual CBT interventions, have been found to help reduce smoking rates and promote and maintain abstinence. Suicidality risks, while present when trying to quit smoking, do not appear to demonstrate a consistent or significant rise associated with use of any particular smoking cessation pharmacotherapy or CBT/contextual CBT intervention reviewed.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleidSART.S33389en
dc.identifier.citationPenberthy, J. K., Penberthy, J. M., Harris, M. R., Nanda, S., Ahn, J., Martinez, C. P., Osika, A. O., Slepian, Z. A., Forsyth, J. C., Starr, J. A., Farrell, J. E. and Hook, J. N. (2016) 'Are Smoking Cessation Treatments Associated with Suicidality Risk? An Overview', Substance Abuse: Research and Treatment, 10, pp. 19-30. doi: 10.4137/SART.S33389en
dc.identifier.doi10.4137/SART.S33389en
dc.identifier.eissn1178-2218
dc.identifier.endpage30en
dc.identifier.journaltitleSubstance Abuse: Research and Treatmenten
dc.identifier.startpage19en
dc.identifier.urihttps://hdl.handle.net/10468/9263
dc.identifier.volume10en
dc.language.isoenen
dc.publisherSAGE Journalsen
dc.rights© 2016, the authors, publisher and licensee Libertas Academica Limited. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 Licenseen
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/en
dc.subjectNicotine dependenceen
dc.subjectSmokingen
dc.subjectSmoking cessationen
dc.subjectSuicidalityen
dc.titleAre smoking cessation treatments associated with suicidality risk? An overviewen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
sart.s33389.pdf
Size:
426.58 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medicine - Journal Articles